H2AX and lung cancer: Is it the Ariadne's thread?MATTHAIOS, D; BOUROS, D; KAKOLYRIS, S et al.DNA repair. 2013, Vol 12, Num 2, pp 90-91, issn 1568-7864, 2 p.Article

Sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II studyMAVROUDIS, D; PAVLAKOU, G; MAGKANAS, E et al.Lung cancer. 2003, Vol 39, Num 1, pp 71-76, issn 0169-5002, 6 p.Article

Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: A multicenter phase II trialSOUGLAKOS, J; MAVROUDIS, D; SAMONIS, G et al.Journal of clinical oncology. 2002, Vol 20, Num 11, pp 2651-2657, issn 0732-183XArticle

Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): A multicenter phase II studyKAKOLYRIS, S; MAVROUDIS, D; TSAVARIS, N et al.Annals of oncology. 2001, Vol 12, Num 2, pp 193-197, issn 0923-7534Article

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trialGEORGOULIAS, V; SAMONIS, G; MAVROUDIS, D et al.Lung cancer. 2001, Vol 34, pp S47-S51, issn 0169-5002, SUP4Conference Paper

Assessement of vascular maturation in lung and breast carcinomas using a novel basement membrane component, LH39KAKOLYRIS, S; GIATROMANOLAKI, A; KOUKOURAKIS, M et al.Anticancer research. 2001, Vol 21, Num 6B, pp 4311-4316, issn 0250-7005Article

Front-line treatment of advanced breast cancer with docetaxel and epirubicin : A multicenter phase II studyMAVROUDIS, D; ALEXOPOULOS, A; RIGATOS, G et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1249-1254, issn 0923-7534Article

Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancerKOUROUSSIS, C; ANDROULAKIS, N; VLACHONIKOLIS, J et al.Journal of clinical oncology. 1999, Vol 17, Num 3, pp 862-869, issn 0732-183XArticle

Salvage chemotherapy with paclitaxel, vinorelbine, and cisplatin (PVC) in anthracycline-resistant advanced breast cancerKOUROUSIS, C; KAKOLYRIS, S; ANDROULAKIS, N et al.American journal of clinical oncology. 1998, Vol 21, Num 3, pp 226-232, issn 0277-3732Article

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trialKOUKOURAKIS, M. I; KOUROUSIS, C; KAMILAKI, M et al.European journal of cancer (1990). 1998, Vol 34, Num 6, pp 838-844, issn 0959-8049Article

Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein : a basis for its role in human diseaseKAKOLYRIS, S; KAKLAMANIS, L; GATTER, K. C et al.Histopathology. 1998, Vol 33, Num 6, pp 561-569, issn 0309-0167Article

P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expressionKOUVIDOU, C; STEFANAKI, K; GEORGOULIAS, V et al.Anticancer research. 1997, Vol 17, Num 4A, pp 2615-2619, issn 0250-7005Article

H2AX a Promising Biomarker for Lung Cancer: A ReviewMATTHAIOS, D; HOUNTIS, P; KARAKITSOS, P et al.Cancer investigation. 2013, Vol 31, Num 1-10, pp 582-599, issn 0735-7907, 18 p.Article

Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)SOUGLAKOS, J; ZIRAS, N; GEORGOULIAS, V et al.British journal of cancer. 2012, Vol 106, Num 3, pp 453-459, issn 0007-0920, 7 p.Article

A dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with capecitabine (Xeloda) in patients with refractory solid tumorsMALTEZOS, E; AMARANTIDIS, K; TRICHAS, M et al.Oncology. 2005, Vol 69, Num 6, pp 463-469, issn 0030-2414, 7 p.Article

Phase I study of Paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) administered every 2 weeks in patients with advanced solid tumorsMAVROUDIS, D; KOUROUSSIS, Ch; KAKOLYRIS, S et al.Oncology. 2002, Vol 62, Num 3, pp 216-222, issn 0030-2414Article

A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancerMAVROUDIS, D; PAPADAKIS, E; VLACHONICOLIS, J et al.Annals of oncology. 2001, Vol 12, Num 4, pp 463-470, issn 0923-7534Article

Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II studyKAKOLYRIS, S; PAPADAKIS, E; AGELAKI, S et al.Lung cancer. 2001, Vol 32, Num 2, pp 179-187, issn 0169-5002Article

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapyKAKOLYRIS, S; SOUGLAKOS, J; AGELAKI, S et al.Lung cancer. 2000, Vol 30, Num 3, pp 193-198, issn 0169-5002Article

Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma : a multicentre phase I studyGIANNAKAKIS, T; ZIRAS, N; VLACHONIKOLIS, J et al.European journal of cancer (1990). 2000, Vol 36, Num 6, pp 742-747, issn 0959-8049Article

Post-chemotherapy lymphopoiesis in patients with solid tumors is characterized by CD4⁺ cell proliferationSARA, E; KOTSAKIS, A; SOUKLAKOS, J et al.Anticancer research. 1999, Vol 19, Num 1A, pp 471-476, issn 0250-7005Article

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer : impact on tumour neoangiogenesis and survivalKOUKOURAKIS, M. I; GIATROMANOLAKI, A; KAKOLYRIS, S et al.British journal of cancer. 1998, Vol 77, Num 10, pp 1696-1703, issn 0007-0920Article

First-line treatment of advanced non-small-cell lung cancer with docetaxel and cisplatin : A multicenter phase II studyGEORGOULIAS, V; ANDROULAKIS, N; HERAS, P et al.Annals of oncology. 1998, Vol 9, Num 3, pp 331-334, issn 0923-7534Article

Docetaxel (taxotere) and gemcitabine in the treatment of non-small cell lung cancer : Preliminary resultsGEORGOULIAS, V; KOUROUSIS, C; KOTSAKIS, T et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S14.22-S14.25, issn 0093-7754, SUP14Article

Second-line treatment of advanced non-small cell lung cancer with paclitaxel and gemcitabine: A preliminary report on an active regimenGEORGOULIAS, V; KOUROUSIS, C; HATZIDAKI, D et al.Seminars in oncology. 1997, Vol 24, Num 4, pp S12.61-S12.66, issn 0093-7754, SUP12Conference Paper